If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Nice RNS and broker notes, wow. Some loading up being going on.
and plenty of buys going through.
100p this week for sure.. Great news
The plot thickens !!!
this last week
https://investegate.co.uk/aortech-inter-plc/rns/development-agreement-signed/201806190930038386R/
Bill Brown, Chairman of AorTech, said: "In partnering with the team at VFT, AorTech now has access to Europe's leading experts in the combined field of medical imaging, guided Finite Element Analysis and Computational Fluid Dynamics. Combining the design history with this ground breaking imaging analysis should much improve the quality of the product design, reliability and performance."
Craig Dunlop, General Manager and Director of VFT, said: "The team at VFT has been very impressed with the quantity and quality of data that AorTech has been able to demonstrate to us. We are very excited to be a key partner in the development of the next generation of prosthetic heart valves which should represent not only a step change in performance, but dramatically reduce the cost to manufacture these life enhancing devices."
now this today
https://investegate.co.uk/aortech-inter-plc/rns/new-patent-issued/201806261249266329S/
Also TR1's with positions being taken
I can only see this going one way ... Well done to those who have been in a while and making serious gains.
Looks great!
I am looking at level 2, there is consistent interest here
Today roughly two shares bought for every one sold. Then we see a 100K buy from yesterday. Unless there is a delayed sell it suggests selling below 40 pence is unlikely to be around for many trading days.
Agreed . It would be nice to get some more figures. But, possibilities are Improving Handsomely. Best of All
Is just the beginning
AorTech International PLC Development Agreement Signed
SALT LAKE CITY, June 4, 2018 /PRNewswire/ -- Biomerics LLC, a medical device contract manufacturer headquartered in Salt Lake City, UT is pleased to announce the acquisition of FutureMatrix Interventional, Inc. FMI, located in Athens, TX specializes in the design and manufacture of interventional catheters for the cardiovascular and urinary markets. "We are pleased to add FMI's capabilities to the Biomerics portfolio," stated Travis Sessions, CEO. "We welcome the FMI team to the group, and look forward to their contribution. This acquisition expands our capabilities and important customer relationships. We look forward to investing in and expanding the business for our customers, employees, and community. Combining FMI with Biomerics' existing medical device business establishes Biomerics as a leader in the attractive minimally invasive interventional segment of the medical device market". FMI, founded in 1993 by James Passmore, started by developing PTA catheters. Over the years, the company expanded its PTA balloon technologies and developed other peripheral cardiovascular, kidney stone management, and urinary catheters. Today, the FDA registered location includes over 50,000 sq. ft. of manufacturing space and employs more than 400 employees. Biomerics, with over 1000 employees, operates seven facilities located in Utah, Minnesota, Indiana, Costa Rica, and Texas. Founded in 2009, Biomerics has grown into a market leader in the minimally invasive interventional catheter market. Biomerics provides engineered components to the medical device market including biomaterials, extrusions, molded parts, laser processed parts, machined parts, balloons, and reinforced shafts. Additionally, it supplies packaged sterile medical devices including advanced interventional catheters, surgical tools, and vascular access products. About Biomerics Biomerics specializes in the design, development, and production of medical devices for diagnostic and interventional procedures for the cardiovascular, structural heart, cardiac rhythm management, and vascular access markets. The company, formed in 2009, provides a full range of engineered components and finished devices to the world's leading medical device OEMs. SOURCE Biomerics, LLC Related Links http://www.biomerics.com
So this is it?
More buyers . Seems to be the future is brighter now than for many years . Best of All
12% stake here....
12% stake in this.…
£1? Lol I’m thinking £3 min
Maybe £1 by Christmas is feasible . Best of All
You can’t say that
Why?
to be announced Friday/Monday
Miton be a good thing. Best of All
Do not be short...
A good day ahead . Best of All
AOR 159 per cent. ACRL percentage take up of 287.64 per cent. Though ACRL in fact was a better value offer ,ie 50% , not 15% discount. All bodes well for Bill & the Team
Couldn't agree more, just posted elsewhere on the two closing trades.